CK

Chand Kumari

Active Director Director DIN 11080064
DIN 11080064 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value •••• Premium profile

About Chand Kumari

Data last updated:

Chand Kumari is a Director at Greenvet Pharmaceutical Private Limited (since 2025). The company operates in Pharma. Greenvet Pharmaceutical Private Limited reported revenue of ₹10.7 Lakh (FY 2024).

DIN 11080064
Primary Designation Director
Industry Pharma
First Appointment 28 Apr 2025
Oldest Company Age 5 yrs
Largest company Greenvet Pharmaceutical Private Limited · ₹10.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20252021₹10.7 Lakh (FY 2024)Active

Board colleagues of Chand Kumari

Directorship timeline

Open interactive timeline →
Greenvet Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Chand Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chand Kumari

Chand Kumari currently holds 1 directorship: Greenvet Pharmaceutical Private Limited (Director, since 28 Apr 2025, revenue ₹10.7 Lakh (FY 2024)).

Chand Kumari was first appointed on 28 Apr 2025 as Director at Greenvet Pharmaceutical Private Limited.

The current boards of Chand Kumari's companies include Ansari (Greenvet Pharmaceutical Private Limited), Vipul Kumar (Greenvet Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available